USANA Health Sciences "hold"

04/13/07 - Wedbush Morgan Securities

NEW YORK, April 13 (newratings.com) - Analysts at Wedbush Morgan maintain their "hold" rating on USANA Health Sciences Inc (USNA). The 12-month target price is set to $47.

In a research note published yesterday, the analysts mention that the company has pre-announced its 1Q revenues at $102 million. The recent sell-off of USANA Health Sciences’ shares appears overdone, the analysts say. According to Wedbush Morgan, the allegations of widespread fraud by the FDI against USANA Health Sciences do not have merit.